Publicaciones
-
Guillén-Gómez E, Pinilla-Macua I, Perez-Torras S, Choi DS, Arce Y, Ballarín JA, Pastor-Anglada M and Díaz-Encarnación MM.
New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells.
JOURNAL OF CELLULAR PHYSIOLOGY . 227(4): 1521-1528. Nº de citas: 20
-
Perez-Torras S, García-Manteiga J, Mercadé E, Casado FJ, Carbó N, Pastor-Anglada M and Mazo A.
Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.
BIOCHEMICAL PHARMACOLOGY . 76(3): 322-329. Nº de citas: 42
-
Mata A, Calvo E, Marsal-Beltran A, Medina-Pulido L, Lozano JJ, Ormazabal-Herrero A, Balaguer-Román A, Frutos MD, Artuch-Iriberri R, Cámara Y, Martí R, Rodrigues CMP, Castro RE, Hernández-Alvarez MI, Ramos-Molina B, Pastor-Anglada M, Fernández-Veledo S and Perez-Torras S.
Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.
METABOLISM-CLINICAL AND EXPERIMENTAL . 183: 156710-156710.
